You are here

  • Home
  • Archive
  • Volume 27, Issue 4
  • Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer

Article info

Article menu
Download PDFPDF
Uterine Cancer
Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer

Authors

  1. Address correspondence and reprint requests to Mi Kyoung Kim, MD, Department of Obstetrics & Gynecology, CHA Gangnam Medical Center, CHA University, 566, Nonhyeon-ro, Gangnam-gu, Seoul 135-081, Republic of Korea. E-mail: rlaalrud80{at}hanmail.net.

Citation

Hwang JY, Kim DH, Bae HS, et al
Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer
International Journal of Gynecologic Cancer 2017;27:738-742.

Publication history

  • Received August 2, 2016
  • Accepted December 12, 2016
  • First published May 1, 2017.
Online issue publication 
January 27, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.